Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Study to Evaluate the Guideline Education of Oncology Departments in Small/Middle Tier Cities and County Hospitals for Diagnosis and Treatment Improvement in Patients With Metastatic Non-small Cell Lung Cancer

NCT06494241 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06494241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06494241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Study to Evaluate the Guideline Education of Oncology Departments in Small/Middle Tier Cities and County Hospitals for Diagnosis and Treatment Improvement in Patients With Metastatic Non-small Cell Lung Cancer
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
November 22, 2024
Completion date
November 28, 2027
Enrollment
1,000 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial neoplasms, carcinoma, bronchogenic, carcinoma, non-small-cell lung, lung diseases, lung neoplasms, neoplasms, neoplasms by site, respiratory tract diseases, respiratory tract neoplasms, thoracic neoplasms